Temat: "Quinolines" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Montelukast, a cysteinyl leukotriene receptor antagonist, exerts local antinociception in animal model of pain through the L-arginine/nitric oxide/cyclic GMP/K ATP channel pathway and PPARγ receptors.
Autorzy:: Alizamani E; Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Ghorbanzadeh B; Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.; Pain Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Naserzadeh R; Department of Pharmacology, School of Medicine, Dezful University of Medical Sciences, Dezful, Iran.
Mansouri MT; Department of Anesthesiology, Columbia University Medical Center, New York, NY, USA.; Pokaż więcej
Źródło:: The International journal of neuroscience [Int J Neurosci] 2021 Oct; Vol. 131 (10), pp. 1004-1011. Date of Electronic Publication: 2020 May 22.
Typ publikacji:: Journal Article
MeSH Terms:: Analgesia*
Acetates/*pharmacology
Analgesics/*pharmacology
Arginine/*drug effects
Cyclic GMP/*metabolism
Cyclopropanes/*pharmacology
KATP Channels/*drug effects
Leukotriene Antagonists/*pharmacology
Nitric Oxide/*metabolism
Nociceptive Pain/*drug therapy
PPAR gamma/*drug effects
Quinolines/*pharmacology
Sulfides/*pharmacology
Acetates/administration & dosage ; Analgesics/administration & dosage ; Animals ; Behavior, Animal/drug effects ; Cyclopropanes/administration & dosage ; Disease Models, Animal ; Leukotriene Antagonists/administration & dosage ; Male ; Quinolines/administration & dosage ; Rats, Wistar ; Signal Transduction/drug effects ; Sulfides/administration & dosage ; Rats

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Ameliorating effect of leukotriene receptor antagonist in multi-organ toxicity induced in rat offspring, a possible role for epidermal growth factor.
Autorzy:: Abdelzaher WY; Department of Pharmacology, Faculty of Medicine, Minia University, El Minia, Egypt.
Rofaeil RR; Department of Pharmacology, Faculty of Medicine, Minia University, El Minia, Egypt.; Department of Pharmacology, Faculty of Pharmacy, Deraya University, Minya, Egypt.
Abdel-Hafez SMN; Department of Histology and Cell Biology, Faculty of Medicine, Minia University, El Minia, Egypt.
Atta M; Department of Anatomy, Faculty of Medicine, Minia University, El Minia, Egypt.
Bahaa El-Deen MA; Department of Pediatric, Faculty of Medicine, Minia University, El Minia, Egypt.
Ali DM; Department of Forensic Medicine and Toxicology, Faculty of Medicine, Minia University, El Minia, Egypt.; Pokaż więcej
Źródło:: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2021 Apr; Vol. 43 (2), pp. 183-191. Date of Electronic Publication: 2021 Jan 27.
Typ publikacji:: Journal Article
MeSH Terms:: Acetates/*pharmacology
Calcification, Physiologic/*drug effects
Cyclopropanes/*pharmacology
Epidermal Growth Factor/*metabolism
Kidney/*drug effects
Kidney/*metabolism
Leukotriene Antagonists/*pharmacology
Quinolines/*pharmacology
Sulfides/*pharmacology
Acetates/therapeutic use ; Animals ; Calcification, Physiologic/physiology ; Cyclopropanes/therapeutic use ; Female ; Kidney/pathology ; Leukotriene Antagonists/therapeutic use ; Male ; Metal Nanoparticles/toxicity ; Oxidative Stress/drug effects ; Oxidative Stress/physiology ; Pregnancy ; Prenatal Exposure Delayed Effects/chemically induced ; Prenatal Exposure Delayed Effects/drug therapy ; Prenatal Exposure Delayed Effects/metabolism ; Quinolines/therapeutic use ; Rats ; Rats, Sprague-Dawley ; Receptors, Leukotriene/metabolism ; Silver/toxicity ; Sulfides/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A Review of Different Analytical Techniques for Fexofenadine Hydrochloride and Montelukast Sodium in Different Matrices.
Autorzy:: Nalini CN; Pharmaceutical Analysis, C.L. Baid Metha College of Pharmacy, Chennai, India.
Kumar V; Pharmaceutical Analysis, C.L. Baid Metha College of Pharmacy, Chennai, India.; Pokaż więcej
Źródło:: Critical reviews in analytical chemistry [Crit Rev Anal Chem] 2021; Vol. 51 (3), pp. 232-245. Date of Electronic Publication: 2020 Jan 03.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Acetates/*analysis
Anti-Allergic Agents/*analysis
Chemistry Techniques, Analytical/*methods
Cyclopropanes/*analysis
Drug Monitoring/*methods
Leukotriene Antagonists/*analysis
Quinolines/*analysis
Sulfides/*analysis
Terfenadine/*analogs & derivatives
Acetates/pharmacokinetics ; Animals ; Anti-Allergic Agents/pharmacokinetics ; Anti-Asthmatic Agents/analysis ; Anti-Asthmatic Agents/pharmacokinetics ; Chemistry Techniques, Analytical/instrumentation ; Cyclopropanes/pharmacokinetics ; Drug Monitoring/instrumentation ; Histamine H1 Antagonists, Non-Sedating/analysis ; Histamine H1 Antagonists, Non-Sedating/pharmacokinetics ; Humans ; Leukotriene Antagonists/pharmacokinetics ; Quinolines/pharmacokinetics ; Sulfides/pharmacokinetics ; Terfenadine/analysis ; Terfenadine/pharmacokinetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The efficacy of a leukotriene receptor antagonist in the treatment of human rectal aberrant crypt foci: a nonrandomized, open-label, controlled trial.
Autorzy:: Higurashi T; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan. takuma_.
Arimoto J; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.
Ashikari K; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.
Takatsu T; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.
Misawa N; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.
Yoshihara T; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.
Matsuura T; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.
Fuyuki A; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.
Ohkubo H; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.
Nakajima A; Department of Gastroenterology and Hepatology, Yokohama City University School of Medicine, 3-9 Fukuura, Kanazawa, Yokohama, Kanagawa, 236-0004, Japan.; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2020 Aug 17; Vol. 20 (1), pp. 770. Date of Electronic Publication: 2020 Aug 17.
Typ publikacji:: Clinical Trial Protocol; Journal Article
MeSH Terms:: Aberrant Crypt Foci/*prevention & control
Acetates/*administration & dosage
Colonic Polyps/*therapy
Cyclopropanes/*administration & dosage
Intestinal Mucosa/*drug effects
Leukotriene Antagonists/*administration & dosage
Quinolines/*administration & dosage
Sulfides/*administration & dosage
Aberrant Crypt Foci/diagnosis ; Aberrant Crypt Foci/pathology ; Aberrant Crypt Foci/surgery ; Acetates/adverse effects ; Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Biopsy ; Cell Proliferation/drug effects ; Colon/diagnostic imaging ; Colon/drug effects ; Colon/pathology ; Colon/surgery ; Colonic Polyps/pathology ; Colonoscopy ; Controlled Clinical Trials as Topic ; Cyclopropanes/adverse effects ; Female ; Humans ; Intestinal Mucosa/diagnostic imaging ; Intestinal Mucosa/pathology ; Intestinal Mucosa/surgery ; Leukotriene Antagonists/adverse effects ; Male ; Middle Aged ; Pilot Projects ; Prospective Studies ; Quinolines/adverse effects ; Rectum/diagnostic imaging ; Rectum/drug effects ; Rectum/pathology ; Rectum/surgery ; Sulfides/adverse effects ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Adverse events associated with weight-based, high-dose montelukast exposures in children.
Autorzy:: Arnold DH; Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA.; Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Center for Asthma Research, Vanderbilt University School of Medicine, Nashville, TN, USA.
Bowman N; Tennessee Poison Center, Nashville, TN, USA.
Reiss TF; Celgene Corporation, Summit, NJ, USA.
Hartert TV; Center for Asthma Research, Vanderbilt University School of Medicine, Nashville, TN, USA.; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Akers WS; Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN, USA.; Department of Pharmaceutical Sciences, Lipscomb University College of Pharmacy, Nashville, TN, USA.
Seger DL; Department of Emergency Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Tennessee Poison Center, Nashville, TN, USA.; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.; Pokaż więcej
Źródło:: Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2020 Feb; Vol. 58 (2), pp. 145-146. Date of Electronic Publication: 2019 May 06.
Typ publikacji:: Letter
MeSH Terms:: Acetates/*administration & dosage
Acetates/*adverse effects
Asthma/*drug therapy
Leukotriene Antagonists/*administration & dosage
Leukotriene Antagonists/*adverse effects
Quinolines/*administration & dosage
Quinolines/*adverse effects
Acetates/therapeutic use ; Body Weight ; Child ; Cyclopropanes ; Dose-Response Relationship, Drug ; Drug Dosage Calculations ; Female ; Humans ; Leukotriene Antagonists/therapeutic use ; Male ; Poison Control Centers ; Quinolines/therapeutic use ; Sulfides

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Involvement of GPR17 in Neuronal Fibre Outgrowth.
Autorzy:: Braune M; Rudolf Boehm Institute of Pharmacology and Toxicology, Medical Faculty, University of Leipzig, Härtelstr. 16-18, 04107 Leipzig, Germany.
Scherf N; Methods and Development Group Neural Data Analysis and Statistical Computing, Max Planck Institute for Human Cognitive and Brain Sciences, Stephanstraße 1A, 04103 Leipzig, Germany.
Heine C; Rudolf Boehm Institute of Pharmacology and Toxicology, Medical Faculty, University of Leipzig, Härtelstr. 16-18, 04107 Leipzig, Germany.
Sygnecka K; Rudolf Boehm Institute of Pharmacology and Toxicology, Medical Faculty, University of Leipzig, Härtelstr. 16-18, 04107 Leipzig, Germany.
Pillaiyar T; Department of Pharmaceutical & Medicinal Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.
Parravicini C; Department of Pharmaceutical Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy.
Heimrich B; Department of Neuroanatomy, Institute of Anatomy and Cell Biology, Center for Basics in NeuroModulation, Faculty of Medicine, University of Freiburg, Albertstr. 23, 79104 Freiburg, Germany.
Abbracchio MP; Department of Pharmaceutical Sciences, University of Milan, Via Balzaretti 9, 20133 Milan, Italy.
Müller CE; Department of Pharmaceutical & Medicinal Chemistry, Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53121 Bonn, Germany.
Franke H; Rudolf Boehm Institute of Pharmacology and Toxicology, Medical Faculty, University of Leipzig, Härtelstr. 16-18, 04107 Leipzig, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Oct 28; Vol. 22 (21). Date of Electronic Publication: 2021 Oct 28.
Typ publikacji:: Journal Article
MeSH Terms:: Acetates/*pharmacology
Cyclopropanes/*pharmacology
Leukotriene Antagonists/*pharmacology
Neuronal Outgrowth/*drug effects
Quinolines/*pharmacology
Receptors, G-Protein-Coupled/*metabolism
Sulfides/*pharmacology
Animals ; Animals, Newborn ; Coculture Techniques ; Drug Evaluation, Preclinical ; Female ; Male ; Nerve Regeneration/drug effects ; Neuronal Outgrowth/genetics ; Rats

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Montelukast and Coronavirus Disease 2019: A Scoping Review.
Autorzy:: Sharifinejad N; Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran AND Alborz Office of Universal Scientific Education and Research Network (USERN), Alborz University of Medical Sciences, Karaj, Iran. .
Sharafian S; Department of Allergy and Clinical Immunology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. .
Salekmoghadam S; Student Research Committee, Alborz University of Medical Sciences, Karaj, Iran. .
Tavakol M; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. .
Qorbani M; Social Determinants of Health Research Center, Alborz University of Medical Sciences, Karaj, Iran. .; Pokaż więcej
Źródło:: Iranian journal of allergy, asthma, and immunology [Iran J Allergy Asthma Immunol] 2021 Aug 07; Vol. 20 (4), pp. 384-393. Date of Electronic Publication: 2021 Aug 07.
Typ publikacji:: Journal Article; Review
MeSH Terms:: COVID-19 Drug Treatment*
Acetates/*therapeutic use
Cyclopropanes/*therapeutic use
Leukotriene Antagonists/*therapeutic use
Quinolines/*therapeutic use
Sulfides/*therapeutic use
Antiviral Agents/therapeutic use ; COVID-19/prevention & control ; Humans ; SARS-CoV-2 ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Montelukast alleviates inflammation in experimental autoimmune encephalomyelitis by altering Th17 differentiation in a mouse model.
Autorzy:: Han B; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Zhang YY; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Ye ZQ; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Xiao Y; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Rasouli J; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
Wu WC; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Ye SM; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Guo XY; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Zhu L; Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Rostami A; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA.
Wang LB; The General Hospital of Ningxia Medical University, Yinchuan, China.
Zhang Y; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.
Li X; National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi'an, China.; Pokaż więcej
Źródło:: Immunology [Immunology] 2021 Jun; Vol. 163 (2), pp. 185-200. Date of Electronic Publication: 2021 Feb 28.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Acetates/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Cyclopropanes/*therapeutic use
Encephalomyelitis, Autoimmune, Experimental/*drug therapy
Inflammation/*drug therapy
Leukotriene Antagonists/*therapeutic use
Multiple Sclerosis/*drug therapy
Quinolines/*therapeutic use
Sulfides/*therapeutic use
Th17 Cells/*immunology
Adoptive Transfer ; Animals ; Cell Differentiation ; Disease Models, Animal ; Female ; Humans ; Mice ; Mice, Inbred C57BL ; Molecular Targeted Therapy ; Receptors, Leukotriene/genetics ; Receptors, Leukotriene/metabolism ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Potential Effects of Leukotriene Receptor Antagonist Montelukast in Treatment of Neuroinflammation in Parkinson's Disease.
Autorzy:: Wallin J; Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.
Svenningsson P; Laboratory of Translational Neuropharmacology, Department of Clinical Neuroscience, Karolinska Institutet, 17177 Stockholm, Sweden.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 May 25; Vol. 22 (11). Date of Electronic Publication: 2021 May 25.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Parkinson Disease*/drug therapy
Parkinson Disease*/metabolism
Parkinson Disease*/pathology
Acetates/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Cyclopropanes/*therapeutic use
Leukotriene Antagonists/*therapeutic use
Quinolines/*therapeutic use
Sulfides/*therapeutic use
Astrocytes/metabolism ; Astrocytes/pathology ; Humans ; Inflammation/drug therapy ; Inflammation/metabolism ; Inflammation/pathology ; Lewy Bodies/metabolism ; Lewy Bodies/pathology ; Microglia/metabolism ; Microglia/pathology ; Receptors, Leukotriene/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The Leukotriene Receptor Antagonist Montelukast Attenuates Neuroinflammation and Affects Cognition in Transgenic 5xFAD Mice.
Autorzy:: Michael J; Institute of Molecular Regenerative Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.
Zirknitzer J; Institute of Molecular Regenerative Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.
Unger MS; Institute of Molecular Regenerative Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.
Poupardin R; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.
Rieß T; Institute of Molecular Regenerative Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.
Paiement N; IntelgenX Corp., Saint-Laurent, QC H4S 1Y2, Canada.
Zerbe H; IntelgenX Corp., Saint-Laurent, QC H4S 1Y2, Canada.
Hutter-Paier B; QPS Neuropharmacology, 8074 Grambach/Graz, Austria.
Reitsamer H; Research Program for Experimental Ophthalmology, Department of Ophthalmology and Optometry, University Hospital of the Paracelsus Medical University, 5020 Salzburg, Austria.
Aigner L; Institute of Molecular Regenerative Medicine, Paracelsus Medical University, 5020 Salzburg, Austria.; Spinal Cord Injury and Tissue Regeneration Center Salzburg (SCI-TReCS), Paracelsus Medical University, 5020 Salzburg, Austria.; Austrian Cluster of Tissue Regeneration, 1200 Vienna, Austria.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Mar 09; Vol. 22 (5). Date of Electronic Publication: 2021 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Acetates/*pharmacology
Alzheimer Disease/*drug therapy
Brain/*metabolism
CD8-Positive T-Lymphocytes/*metabolism
Cognition/*drug effects
Cyclopropanes/*pharmacology
Leukotriene Antagonists/*pharmacology
Quinolines/*pharmacology
Sulfides/*pharmacology
Alzheimer Disease/genetics ; Alzheimer Disease/metabolism ; Alzheimer Disease/pathology ; Animals ; Brain/pathology ; CD8-Positive T-Lymphocytes/pathology ; Inflammation/drug therapy ; Inflammation/metabolism ; Inflammation/pathology ; Mice ; Mice, Transgenic

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Protective effect of melatonin versus montelukast in cisplatin-induced seminiferous tubule damage in rats.
Autorzy:: El-Shafaei A; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Abdelmaksoud R; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Elshorbagy A; Department of Physiology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Zahran N; Department of Histology and Cell biology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Elabd R; Department of Dermatology, Venereology and Andrology, Faculty of Medicine, Alexandria University, Alexandria, Egypt.; Pokaż więcej
Źródło:: Andrologia [Andrologia] 2018 Nov; Vol. 50 (9), pp. e13077. Date of Electronic Publication: 2018 Jul 17.
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Acetates/*therapeutic use
Antioxidants/*therapeutic use
Leukotriene Antagonists/*therapeutic use
Melatonin/*therapeutic use
Quinolines/*therapeutic use
Testicular Diseases/*prevention & control
Acetates/pharmacology ; Animals ; Antineoplastic Agents/adverse effects ; Antioxidants/pharmacology ; Body Weight/drug effects ; Cisplatin/adverse effects ; Cyclopropanes ; Drug Evaluation, Preclinical ; Leukotriene Antagonists/pharmacology ; Male ; Melatonin/pharmacology ; Organ Size/drug effects ; Oxidative Stress/drug effects ; Quinolines/pharmacology ; Rats, Wistar ; Semen Analysis ; Seminiferous Tubules/drug effects ; Seminiferous Tubules/pathology ; Sulfides ; Testicular Diseases/chemically induced

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Montelukast reduces inhaled chlorine triggered airway hyperresponsiveness and airway inflammation in the mouse.
Autorzy:: Hamamoto Y; Meakins-Christie Laboratories, The Research Institute of McGill University Health Centre and the Department of Medicine, McGill University, Montreal, QC, Canada.
Ano S; Meakins-Christie Laboratories, The Research Institute of McGill University Health Centre and the Department of Medicine, McGill University, Montreal, QC, Canada.
Allard B; Meakins-Christie Laboratories, The Research Institute of McGill University Health Centre and the Department of Medicine, McGill University, Montreal, QC, Canada.
O'Sullivan M; Meakins-Christie Laboratories, The Research Institute of McGill University Health Centre and the Department of Medicine, McGill University, Montreal, QC, Canada.
McGovern TK; Meakins-Christie Laboratories, The Research Institute of McGill University Health Centre and the Department of Medicine, McGill University, Montreal, QC, Canada.
Martin JG; Meakins-Christie Laboratories, The Research Institute of McGill University Health Centre and the Department of Medicine, McGill University, Montreal, QC, Canada.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2017 Oct; Vol. 174 (19), pp. 3346-3358. Date of Electronic Publication: 2017 Aug 23.
Typ publikacji:: Journal Article
MeSH Terms:: Acetates/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Chlorine/*toxicity
Irritants/*toxicity
Leukotriene Antagonists/*therapeutic use
Quinolines/*therapeutic use
Respiratory Hypersensitivity/*drug therapy
Acetates/pharmacology ; Animals ; Anti-Inflammatory Agents/pharmacology ; Antibodies, Monoclonal/pharmacology ; Bronchoalveolar Lavage Fluid/immunology ; Cell Line ; Cyclopropanes ; Cytokines/immunology ; Leukotriene Antagonists/pharmacology ; Lung/drug effects ; Lung/metabolism ; Male ; Mice, Inbred BALB C ; NF-E2-Related Factor 2/metabolism ; Quinolines/pharmacology ; Receptors, Interleukin-6/immunology ; Respiratory Hypersensitivity/chemically induced ; Sulfides

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Real-life experience in the treatment of solar urticaria: retrospective cohort study.
Autorzy:: Snast I; Photodermatosis Service, Department of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lapidoth M; Photodermatosis Service, Department of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Uvaidov V; Photodermatosis Service, Department of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Enk CD; Department of Dermatology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Mazor S; Department of Community Dentistry, School of Dental Medicine, Hebrew University-Hadassah Medical Center, Jerusalem, Israel.
Hodak E; Photodermatosis Service, Department of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Levi A; Photodermatosis Service, Department of Dermatology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.; Pokaż więcej
Źródło:: Clinical and experimental dermatology [Clin Exp Dermatol] 2019 Jul; Vol. 44 (5), pp. e164-e170. Date of Electronic Publication: 2019 Apr 13.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Allergic Agents/*therapeutic use
Histamine Antagonists/*therapeutic use
Leukotriene Antagonists/*therapeutic use
Omalizumab/*therapeutic use
Photosensitivity Disorders/*drug therapy
Urticaria/*drug therapy
Acetates/therapeutic use ; Adolescent ; Adult ; Aged ; Cetirizine/therapeutic use ; Child ; Cohort Studies ; Cyclopropanes ; Disease Management ; Female ; Humans ; Loratadine/analogs & derivatives ; Loratadine/therapeutic use ; Male ; Middle Aged ; Quinolines/therapeutic use ; Retrospective Studies ; Sulfides ; Terfenadine/analogs & derivatives ; Terfenadine/therapeutic use ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product.
Autorzy:: Chen Y; a School of Pharmacy, East China University of Science and Technology , Shanghai , P.R. China.
Feng T; a School of Pharmacy, East China University of Science and Technology , Shanghai , P.R. China.
Li Y; a School of Pharmacy, East China University of Science and Technology , Shanghai , P.R. China.
Du B; a School of Pharmacy, East China University of Science and Technology , Shanghai , P.R. China.
Weng W; a School of Pharmacy, East China University of Science and Technology , Shanghai , P.R. China.; Pokaż więcej
Źródło:: Pharmaceutical development and technology [Pharm Dev Technol] 2017 Mar; Vol. 22 (2), pp. 168-172. Date of Electronic Publication: 2015 Dec 10.
Typ publikacji:: Journal Article
MeSH Terms:: Acetates/*chemistry
Anti-Asthmatic Agents/*chemistry
Leukotriene Antagonists/*chemistry
Quinolines/*chemistry
Acetates/administration & dosage ; Administration, Oral ; Anti-Asthmatic Agents/administration & dosage ; Cyclopropanes ; Drug Compounding ; Drug Liberation ; Hardness ; Leukotriene Antagonists/administration & dosage ; Quinolines/administration & dosage ; Solubility ; Sulfides ; Tablets ; Wettability

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Therapeutic effect of budesonide/formoterol, montelukast and N-acetylcysteine for bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation.
Autorzy:: Kim SW; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Rhee CK; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim YJ; Division of Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Lee S; Division of Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Kim HJ; Division of Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Lee JW; Division of Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, Korea. .; Pokaż więcej
Źródło:: Respiratory research [Respir Res] 2016 May 26; Vol. 17 (1), pp. 63. Date of Electronic Publication: 2016 May 26.
Typ publikacji:: Journal Article
MeSH Terms:: Acetates/*therapeutic use
Acetylcysteine/*therapeutic use
Adrenergic beta-2 Receptor Agonists/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Antioxidants/*therapeutic use
Bronchiolitis Obliterans/*drug therapy
Bronchodilator Agents/*therapeutic use
Budesonide, Formoterol Fumarate Drug Combination/*therapeutic use
Glucocorticoids/*therapeutic use
Hematopoietic Stem Cell Transplantation/*adverse effects
Leukotriene Antagonists/*therapeutic use
Lung/*drug effects
Quinolines/*therapeutic use
Acetates/adverse effects ; Acetylcysteine/adverse effects ; Adrenergic beta-2 Receptor Agonists/adverse effects ; Adult ; Anti-Inflammatory Agents/adverse effects ; Antioxidants/adverse effects ; Bronchiolitis Obliterans/diagnosis ; Bronchiolitis Obliterans/etiology ; Bronchiolitis Obliterans/physiopathology ; Bronchodilator Agents/adverse effects ; Budesonide, Formoterol Fumarate Drug Combination/adverse effects ; Cyclopropanes ; Drug Therapy, Combination ; Female ; Forced Expiratory Volume ; Glucocorticoids/adverse effects ; Humans ; Leukotriene Antagonists/adverse effects ; Lung/physiopathology ; Male ; Middle Aged ; Quinolines/adverse effects ; Recovery of Function ; Retrospective Studies ; Sulfides ; Time Factors ; Treatment Outcome ; Vital Capacity

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis.
Autorzy:: Chen H; Department of Otolaryngology-Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.; Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
Lou H; Department of Otolaryngology-Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
Wang Y; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.
Cao F; Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
Zhang L; Department of Otolaryngology-Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.; Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.
Wang C; Department of Otolaryngology-Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Beijing Key Laboratory of Nasal Diseases, Beijing Institute of Otolaryngology, Beijing, China.; Department of Allergy, Beijing TongRen Hospital, Capital Medical University, Beijing, China.; Pokaż więcej
Źródło:: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2018 Nov; Vol. 8 (11), pp. 1242-1252. Date of Electronic Publication: 2018 Aug 24.
Typ publikacji:: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Acetates/*therapeutic use
Anti-Inflammatory Agents/*therapeutic use
Budesonide/*therapeutic use
Leukotriene Antagonists/*therapeutic use
Quinolines/*therapeutic use
Rhinitis, Allergic, Seasonal/*drug therapy
Administration, Intranasal ; Adolescent ; Adult ; Cyclopropanes ; Drug Therapy, Combination ; Female ; Humans ; Male ; Middle Aged ; Sulfides ; Treatment Outcome ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Cysteinyl leukotriene receptor antagonists induce apoptosis and inhibit proliferation of human glioblastoma cells by downregulating B-cell lymphoma 2 and inducing cell cycle arrest.
Autorzy:: Piromkraipak P; a Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand.
Parakaw T; b Department of Pharmacology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
Phuagkhaopong S; a Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand.
Srihirun S; b Department of Pharmacology, Faculty of Dentistry, Mahidol University, Bangkok, Thailand.
Chongthammakun S; c Department of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand.
Chaithirayanon K; c Department of Anatomy, Faculty of Science, Mahidol University, Bangkok, Thailand.
Vivithanaporn P; a Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand.; Pokaż więcej
Źródło:: Canadian journal of physiology and pharmacology [Can J Physiol Pharmacol] 2018 Aug; Vol. 96 (8), pp. 798-806. Date of Electronic Publication: 2018 May 04.
Typ publikacji:: Journal Article
MeSH Terms:: Apoptosis/*drug effects
Cell Cycle Checkpoints/*drug effects
Down-Regulation/*drug effects
Glioblastoma/*genetics
Glioblastoma/*pathology
Leukotriene Antagonists/*pharmacology
Proto-Oncogene Proteins c-bcl-2/*genetics
Acetates ; Cell Cycle Proteins/genetics ; Cell Cycle Proteins/metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cyclopropanes ; Down-Regulation/genetics ; G1 Phase/drug effects ; G1 Phase/genetics ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Indoles ; Phenylcarbamates ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Quinolines ; Resting Phase, Cell Cycle/drug effects ; Resting Phase, Cell Cycle/genetics ; Sulfides ; Sulfonamides ; Tosyl Compounds ; Up-Regulation/drug effects ; Up-Regulation/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Early Discontinuation of Montelukast Treatment; A Danish Nationwide Utilization Study.
Autorzy:: Farah RI; Clinical Pharmacology and Pharmacy, Department of Public Health, University of Southern Denmark, Odense, Denmark.
Damkier P; Department of Clinical Biochemistry & Pharmacology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Christiansen A; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark.
Henriksen DP; Department of Clinical Biochemistry & Pharmacology, Odense University Hospital, Odense, Denmark.; Department of Clinical Research, University of Southern Denmark, Odense, Denmark.; Department of Respiratory Medicine, Odense University Hospital, Odense, Denmark.; Pokaż więcej
Źródło:: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2018 Jul; Vol. 123 (1), pp. 78-83. Date of Electronic Publication: 2018 Mar 30.
Typ publikacji:: Journal Article
MeSH Terms:: Acetates/*therapeutic use
Asthma/*drug therapy
Drug Utilization/*statistics & numerical data
Leukotriene Antagonists/*therapeutic use
Quinolines/*therapeutic use
Registries/*statistics & numerical data
Administration, Inhalation ; Administration, Oral ; Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Cyclopropanes ; Denmark ; Drug Prescriptions/statistics & numerical data ; Drug Utilization/trends ; Female ; Glucocorticoids/therapeutic use ; Humans ; Infant ; Infant, Newborn ; Male ; Middle Aged ; Off-Label Use/statistics & numerical data ; Patents as Topic ; Patient Compliance/statistics & numerical data ; Risk Factors ; Sulfides ; Time Factors ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Combination therapy of fexofenadine and montelukast is effective in prurigo nodularis and pemphigoid nodularis.
Autorzy:: Shintani T; Department of Dermatology, Kurume University School of Medicine, and Kurume University Institute of Cutaneous Cell Biology, Kurume, Fukuoka, Japan.
Ohata C
Koga H
Ohyama B
Hamada T
Nakama T
Furumura M
Tsuruta D
Ishii N
Hashimoto T; Pokaż więcej
Źródło:: Dermatologic therapy [Dermatol Ther] 2014 May-Jun; Vol. 27 (3), pp. 135-9. Date of Electronic Publication: 2013 Sep 17.
Typ publikacji:: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Acetates/*therapeutic use
Histamine H1 Antagonists, Non-Sedating/*therapeutic use
Leukotriene Antagonists/*therapeutic use
Pemphigoid, Bullous/*drug therapy
Prurigo/*drug therapy
Quinolines/*therapeutic use
Skin/*drug effects
Terfenadine/*analogs & derivatives
Acetates/administration & dosage ; Adult ; Aged ; Aged, 80 and over ; Cyclopropanes ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; Histamine H1 Antagonists, Non-Sedating/administration & dosage ; Humans ; Leukotriene Antagonists/administration & dosage ; Male ; Middle Aged ; Pemphigoid, Bullous/diagnosis ; Prurigo/diagnosis ; Quinolines/administration & dosage ; Skin/pathology ; Sulfides ; Terfenadine/administration & dosage ; Terfenadine/therapeutic use ; Time Factors ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Montelukast for bronchiolitis obliterans syndrome after lung transplantation: A randomized controlled trial.
Autorzy:: Ruttens D; KULeuven and UZ Leuven, Dept. of Clinical and Experimental Medicine, Division of Respiratory Diseases, Lung Transplant Unit, Leuven, Belgium.
Verleden SE; KULeuven and UZ Leuven, Dept. of Clinical and Experimental Medicine, Division of Respiratory Diseases, Lung Transplant Unit, Leuven, Belgium.
Demeyer H; KU Leuven, Department of Rehabilitation Sciences, Leuven, Belgium.
Van Raemdonck DE; KULeuven and UZ Leuven, Dept. of Clinical and Experimental Medicine, Division of Respiratory Diseases, Lung Transplant Unit, Leuven, Belgium.
Yserbyt J; KULeuven and UZ Leuven, Dept. of Clinical and Experimental Medicine, Division of Respiratory Diseases, Lung Transplant Unit, Leuven, Belgium.
Dupont LJ; KULeuven and UZ Leuven, Dept. of Clinical and Experimental Medicine, Division of Respiratory Diseases, Lung Transplant Unit, Leuven, Belgium.
Vanaudenaerde BM; KULeuven and UZ Leuven, Dept. of Clinical and Experimental Medicine, Division of Respiratory Diseases, Lung Transplant Unit, Leuven, Belgium.
Vos R; KULeuven and UZ Leuven, Dept. of Clinical and Experimental Medicine, Division of Respiratory Diseases, Lung Transplant Unit, Leuven, Belgium.
Verleden GM; KULeuven and UZ Leuven, Dept. of Clinical and Experimental Medicine, Division of Respiratory Diseases, Lung Transplant Unit, Leuven, Belgium.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2018 Apr 06; Vol. 13 (4), pp. e0193564. Date of Electronic Publication: 2018 Apr 06 (Print Publication: 2018).
Typ publikacji:: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:: Acetates/*therapeutic use
Bronchiolitis Obliterans/*drug therapy
Leukotriene Antagonists/*therapeutic use
Lung/*physiopathology
Lung Transplantation/*adverse effects
Quinolines/*therapeutic use
Bronchiolitis Obliterans/etiology ; Bronchiolitis Obliterans/mortality ; Bronchiolitis Obliterans/physiopathology ; Cyclopropanes ; Double-Blind Method ; Female ; Forced Expiratory Volume ; Graft Rejection ; Humans ; Lung Transplantation/mortality ; Male ; Middle Aged ; Respiratory Function Tests ; Sulfides ; Survival Rate ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Quinolines"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język